Time Well Spent: Clinical Predictors of Days Alive and Out of the Hospital After Heart Transplantation

Elissa Driggin1, Carolina Lemos1, Shruti Bidani1

  • 1Center for Advanced Cardiac Care, Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.

PubMed

Insights

Older age, kidney disease, and longer hospital stays predict fewer days alive and out of the hospital after heart transplantation (HT). These factors are crucial for improving patient outcomes post-transplant.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Health Services Research

Background:

  • Days Alive and Out of Hospital (DAOH) is a patient-centered outcome gaining traction in heart failure research.
  • DAOH has not been extensively studied in the context of heart transplantation (HT).
  • Understanding DAOH predictors is vital for improving post-transplant care.

Purpose of the Study:

  • To identify predictors of 1-year DAOH after heart transplantation.
  • To analyze DAOH in a diverse patient population at a high-volume transplant center.

Main Methods:

  • Retrospective analysis of 1141 adult HT recipients (2005-2022).
  • Collected baseline demographics and psychosocial factors (insurance, education, language, SES).
  • Primary outcome: DAOH at 1 year, accounting for readmissions and rehabilitation stays.

Main Results:

  • Mean DAOH was 306 days; 6.3% died during index hospitalization.
  • 56% of discharged patients were readmitted within the first year.
  • Older age, chronic kidney disease, post-2018 allocation changes, and longer index hospitalization predicted fewer DAOH.

Conclusions:

  • DAOH is a valuable metric for assessing health-related quality of life post-HT.
  • Integrating patient-centered outcomes like DAOH is essential for the transplant community.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
65
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
353
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
85